These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10787436)

  • 1. Relationship between structure and biochemical phenotype of lecithin:cholesterol acyltransferase (LCAT) mutants causing fish-eye disease.
    Vanloo B; Peelman F; Deschuymere K; Taveirne J; Verhee A; Gouyette C; Labeur C; Vandekerckhove J; Tavernier J; Rosseneu M
    J Lipid Res; 2000 May; 41(5):752-61. PubMed ID: 10787436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and functional properties of two mutants of lecithin-cholesterol acyltransferase (T123I and N228K).
    Adimoolam S; Jin L; Grabbe E; Shieh JJ; Jonas A
    J Biol Chem; 1998 Dec; 273(49):32561-7. PubMed ID: 9829992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of N-terminal amino acids from human lecithin:cholesterol acyltransferase differentially affects enzyme activity toward alpha- and beta-substrate lipoproteins.
    Vickaryous NK; Teh EM; Stewart B; Dolphin PJ; Too CK; McLeod RS
    Biochim Biophys Acta; 2003 Mar; 1646(1-2):164-72. PubMed ID: 12637024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of individual amino acids of apolipoprotein A-I in the activation of lecithin:cholesterol acyltransferase and in HDL rearrangements.
    Cho KH; Durbin DM; Jonas A
    J Lipid Res; 2001 Mar; 42(3):379-89. PubMed ID: 11254750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surface plasmon resonance biosensor studies of human wild-type and mutant lecithin cholesterol acyltransferase interactions with lipoproteins.
    Jin L; Shieh JJ; Grabbe E; Adimoolam S; Durbin D; Jonas A
    Biochemistry; 1999 Nov; 38(47):15659-65. PubMed ID: 10569952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of natural mutations in lecithin:cholesterol acyltransferase on the enzyme structure and activity.
    Peelman F; Verschelde JL; Vanloo B; Ampe C; Labeur C; Tavernier J; Vandekerckhove J; Rosseneu M
    J Lipid Res; 1999 Jan; 40(1):59-69. PubMed ID: 9869650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of mutations of N- and C-terminal charged residues on the activity of LCAT.
    Peelman F; Vanloo B; Verschelde JL; Labeur C; Caster H; Taveirne J; Verhee A; Duverger N; Vandekerckhove J; Tavernier J; Rosseneu M
    J Lipid Res; 2001 Apr; 42(4):471-9. PubMed ID: 11290818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant lecithin:cholesterol acyltransferase containing a Thr123-->Ile mutation esterifies cholesterol in low density lipoprotein but not in high density lipoprotein.
    O K; Hill JS; Wang X; Pritchard PH
    J Lipid Res; 1993 Jan; 34(1):81-8. PubMed ID: 8445345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of glutamic acid residues 154, 155, and 165 of lecithin:cholesterol acyltransferase in cholesterol esterification and phospholipase A2 activities.
    Wang J; DeLozier JA; Gebre AK; Dolphin PJ; Parks JS
    J Lipid Res; 1998 Jan; 39(1):51-8. PubMed ID: 9469585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compound heterozygosity (G71R/R140H) in the lecithin:cholesterol acyltransferase (LCAT) gene results in an intermediate phenotype between LCAT-deficiency and fish-eye disease.
    Hörl G; Kroisel PM; Wagner E; Tiran B; Petek E; Steyrer E
    Atherosclerosis; 2006 Jul; 187(1):101-9. PubMed ID: 16216249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and functional analysis of missense mutations in the lecithin cholesterol acyltransferase gene in a Chilean patient with hypoalphalipoproteinemia.
    Tobar HE; Cataldo LR; González T; Rodríguez R; Serrano V; Arteaga A; Álvarez-Mercado A; Lagos CF; Vicuña L; Miranda JP; Pereira A; Bravo C; Aguilera CM; Eyheramendy S; Uauy R; Martínez Á; Gil Á; Francone O; Rigotti A; Santos JL
    Lipids Health Dis; 2019 Jun; 18(1):132. PubMed ID: 31164121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro expression of natural mutants of human lecithin:cholesterol acyltransferase.
    Qu SJ; Fan HZ; Blanco-Vaca F; Pownall HJ
    J Lipid Res; 1995 May; 36(5):967-74. PubMed ID: 7658168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arginine 123 of apolipoprotein A-I is essential for lecithin:cholesterol acyltransferase activity.
    Gorshkova IN; Mei X; Atkinson D
    J Lipid Res; 2018 Feb; 59(2):348-356. PubMed ID: 29208698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The carboxyl-terminal hydrophobic residues of apolipoprotein A-I affect its rate of phospholipid binding and its association with high density lipoprotein.
    Laccotripe M; Makrides SC; Jonas A; Zannis VI
    J Biol Chem; 1997 Jul; 272(28):17511-22. PubMed ID: 9211897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of N-linked glycosylation of lecithin:cholesterol acyltransferase in lipoprotein substrate specificity.
    O K; Hill JS; Pritchard PH
    Biochim Biophys Acta; 1995 Jan; 1254(2):193-7. PubMed ID: 7827124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site-directed mutagenesis and structure-function analysis of the human apolipoprotein A-I. Relation between lecithin-cholesterol acyltransferase activation and lipid binding.
    Minnich A; Collet X; Roghani A; Cladaras C; Hamilton RL; Fielding CJ; Zannis VI
    J Biol Chem; 1992 Aug; 267(23):16553-60. PubMed ID: 1644835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-chain polyunsaturated fatty acids in the sn-2 position of phosphatidylcholine decrease the stability of recombinant high density lipoprotein apolipoprotein A-I and the activation energy of the lecithin:cholesterol acyltransferase reaction.
    Parks JS; Gebre AK
    J Lipid Res; 1997 Feb; 38(2):266-75. PubMed ID: 9162746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of central alpha-helices of human apolipoprotein A-I in the maturation of high-density lipoproteins.
    Frank PG; N'Guyen D; Franklin V; Neville T; Desforges M; Rassart E; Sparks DL; Marcel YL
    Biochemistry; 1998 Sep; 37(39):13902-9. PubMed ID: 9753480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein A-I helix 6 negatively charged residues attenuate lecithin-cholesterol acyltransferase (LCAT) reactivity.
    Alexander ET; Bhat S; Thomas MJ; Weinberg RB; Cook VR; Bharadwaj MS; Sorci-Thomas M
    Biochemistry; 2005 Apr; 44(14):5409-19. PubMed ID: 15807534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the surface lipid composition of reconstituted LPA-I on apolipoprotein A-I structure and lecithin: cholesterol acyltransferase activity.
    Sparks DL; Frank PG; Neville TA
    Biochim Biophys Acta; 1998 Feb; 1390(2):160-72. PubMed ID: 9507105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.